抗アレルギー薬の世界市場レポート 2025年

抗アレルギー薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で584億7,000万米ドルに成長します。今後の成長を促進する要因としては、世界のアレルギー負担の増加、急速緩和薬への嗜好の高まり、アレルギーを起こしやすい人口の高齢化、eファーマシープラットフォームの普及、アレルギー教育に対する政府の支援強化などが挙げられます。同市場に期待される主要動向としては、ドラッグデリバリー技術の革新、眠くならない抗ヒスタミン薬の出現、オーダーメイドのアレルギー治療の進歩、生物学的療法の研究開発拡大、アレルギー症状管理のためのデジタルツールの利用などが挙げられます。

アレルギーの有病率の増加は、抗アレルギー薬市場の成長を促進すると予想されます。アレルギーは、花粉、ダニ、特定の食物、ペットのフケなどのアレルゲンに対する過敏な免疫反応であり、軽度の刺激から生命を脅かす可能性のある重篤な反応まで、さまざまな症状を引き起こします。花粉症、喘息、湿疹、食物アレルギー、アレルギー性鼻炎などです。アレルギーの患者数の増加は、免疫系を弱め、一般的なアレルゲンに対する感受性を高める環境汚染の増加が主要原因となっています。抗アレルギー薬は、これらのアレルゲンから的を絞った緩和をもたらし、花粉症、喘息、湿疹などの症状を管理するのに不可欠なものとなっています。これらの医薬品は、ヒスタミンやその他の誘因をブロックすることで免疫の過剰反応を抑え、日々の快適さと生活の質を向上させています。例えば、2024年11月、米国疾病予防管理センターは、米国における喘息患者数が2021年の2,496万3,874人から2022年には2,679万9,588人に増加したと報告しました。この喘息患者の増加は、効果的なアレルギー治療に対するニーズの拡大を強調し、抗アレルギー薬市場の成長を支えています。

抗アレルギー薬市場の主要参入企業は、より的を絞った治療を提供し、治療成果を高め、副作用を軽減し、重篤なアレルギー症状に対処するために、モノクローナル抗体治療などの革新的な治療法の開発と規制当局の承認取得に注力しています。モノクローナル抗体療法は、アレルギー反応に関与する特定の免疫経路を標的とし遮断することで、免疫系の機能を模倣するように設計された実験室内で設計されたタンパク質です。これにより、より正確で持続的な症状緩和が可能となります。例えば、2024年12月、スイスに本社を置く製薬会社ガルデルマSAは、中等度から重度のアトピー性皮膚炎を有する12歳以上の成人と小児の治療として、ネムルビオ（ネモリズマブ・イルト）のFDA承認を取得しました。このモノクローナル抗体は、外用コルチコステロイドまたはカルシニューリン阻害剤と併用することで、インターロイキン-31受容体アンタゴニストとして作用し、アトピー性皮膚炎に伴う炎症やかゆみの重要な因子であるIL-31シグナルを遮断することにより、皮膚の状態を改善し、症状を軽減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の抗アレルギー薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の抗アレルギー薬市場：成長率分析
• 世界の抗アレルギー薬市場の実績：規模と成長、2019～2024年
• 世界の抗アレルギー薬市場の予測：規模と成長、2024～2029年、2034年
• 世界の抗アレルギー薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の抗アレルギー薬市場：薬剤クラス別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗ヒスタミン薬
• コルチコステロイド
• 充血除去薬剤
• ロイコトリエン阻害剤
• 肥満細胞安定剤
• その他の薬剤クラス
• 世界の抗アレルギー薬市場：アレルギータイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 季節性アレルギー
• 通年性アレルギー
• 食物アレルギー
• 皮膚アレルギー
• 虫刺されアレルギー
• 世界の抗アレルギー薬市場：配合別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• シロップ
• 鼻スプレー
• 目薬
• 注射剤
• 世界の抗アレルギー薬市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• オンライン薬局
• 病院
• オフライン薬局
• クリニック
• その他
• 世界の抗アレルギー薬市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 幼児
• 成人
• 高齢者
• 妊婦
• 世界の抗アレルギー薬市場、抗ヒスタミン薬剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 第一世代抗ヒスタミン薬
• 第二世代抗ヒスタミン薬
• 第三世代抗ヒスタミン薬
• 世界の抗アレルギー薬市場、コルチコステロイドのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口コルチコステロイド
• 鼻腔コルチコステロイド
• 吸入コルチコステロイド
• 局所コルチコステロイド
• 世界の抗アレルギー薬市場、充血除去薬剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口充血除去薬
• 鼻づまり解消スプレー
• 局所充血除去薬
• 世界の抗アレルギー薬市場、ロイコトリエン阻害剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ロイコトリエン受容体拮抗薬
• ロイコトリエン合成阻害剤
• 世界の抗アレルギー薬市場、肥満細胞安定剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• クロモグリク酸ナトリウム
• ネドクロミルナトリウム
• 世界の抗アレルギー薬市場、その他の薬剤クラスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 免疫療法剤
• 生物製剤
• モノクローナル抗体

第7章 地域別・国別分析

• 世界の抗アレルギー薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の抗アレルギー薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗アレルギー薬市場：競合情勢
• 抗アレルギー薬市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche AG
  • Merck & Co. Inc.
  • Bayer AG

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• AstraZeneca plc
• Novartis AG
• GSK plc
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Perrigo Company plc
• Cipla Limited
• Dr. Reddy's Laboratories
• Lupin Limited
• Zydus Lifesciences Limited
• Takeda Pharmaceutical Company Limited
• Torrent Pharmaceuticals Ltd.
• ALK-Abello A/S

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 抗アレルギー薬市場、2029年：新たな機会を提供する国
• 抗アレルギー薬市場、2029年：新たな機会を提供するセグメント
• 抗アレルギー薬市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Anti-allergy medicine encompasses a wide range of pharmaceutical products formulated to prevent or ease symptoms triggered by allergic reactions. These medications work by targeting the immune system's response to allergens such as pollen, dust mites, pet dander, insect bites, specific foods, and drugs. They help alleviate discomfort by addressing symptoms like sneezing, itching, nasal congestion, hives, and watery eyes.

The primary categories of anti-allergy drugs include antihistamines, corticosteroids, decongestants, leukotriene receptor antagonists, mast cell stabilizers, and other related classes. Antihistamines function by blocking the action of histamine, a compound released by the immune system during allergic responses. These are used to manage various allergy types, including seasonal, perennial, food, skin, and insect bite allergies. Based on formulation, these medicines are available as tablets, capsules, syrups, nasal sprays, eye drops, and injectables. Distribution channels include online pharmacies, hospitals, retail pharmacies, clinics, and others, and they cater to diverse end-user groups such as children, adults, the elderly, and pregnant individuals.

The anti-allergy medicine market research report is one of a series of new reports from The Business Research Company that provides anti-allergy medicine market statistics, including the anti-allergy medicine industry global market size, regional shares, competitors with the anti-allergy medicine market share, detailed anti-allergy medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the anti-allergy medicine industry. These anti-allergy medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anti-allergy medicine market size has grown strongly in recent years. It will grow from $38.84 billion in 2024 to $42.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. This growth during the historic period can be credited to the increasing number of allergic conditions, heightened public awareness about allergy management, wider availability of over-the-counter allergy remedies, better access to healthcare services, and advancements in allergy diagnostic tools.

The anti-allergy medicine market size is expected to see strong growth in the next few years. It will grow to $58.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. Factors driving future growth include a rising global allergy burden, growing preference for rapid-relief medications, an aging population prone to allergies, the proliferation of e-pharmacy platforms, and enhanced governmental support for allergy education. Key trends expected in the market include innovations in drug delivery technologies, the emergence of non-drowsy antihistamines, advancements in customized allergy treatments, expanded R&D in biologic therapies, and the use of digital tools for managing allergic conditions.

The increasing prevalence of allergies is anticipated to drive the growth of the anti-allergy medicine market. Allergies are hypersensitive immune responses to allergens such as pollen, dust mites, certain foods, or pet dander, and can cause symptoms ranging from mild irritation to severe, potentially life-threatening reactions. These include hay fever, asthma, eczema, food allergies, and allergic rhinitis. The rise in allergy cases is largely attributed to growing environmental pollution, which can weaken the immune system and increase sensitivity to common allergens. Anti-allergy medicines provide targeted relief from these allergens, making them essential for managing conditions like hay fever, asthma, and eczema. These medications work by blocking histamines and other triggers, reducing immune overreactions and enhancing daily comfort and quality of life. For example, in November 2024, the Centers for Disease Control and Prevention reported that the number of people with asthma in the United States increased from 24,963,874 in 2021 to 26,799,588 in 2022. This rise in asthma cases underscores the expanding need for effective allergy treatments and supports the growth of the anti-allergy medicine market.

Key players in the anti-allergy medicine market are concentrating on the development of innovative therapies and obtaining regulatory approvals, such as monoclonal antibody treatments, to offer more targeted care, enhance treatment outcomes, reduce side effects, and address severe allergic conditions. Monoclonal antibody therapies are laboratory-engineered proteins designed to mimic the immune system's function by targeting and blocking specific immune pathways involved in allergic responses. This provides more precise and sustained symptom relief. For instance, in December 2024, Galderma SA, a pharmaceutical company based in Switzerland, received FDA approval for Nemluvio (nemolizumab-ilto) to treat adults and children aged 12 and older with moderate to severe atopic dermatitis. Used in combination with topical corticosteroids or calcineurin inhibitors, this monoclonal antibody acts as an interleukin-31 receptor antagonist, blocking IL-31 signaling-an important factor in inflammation and itching associated with atopic dermatitis-thereby helping improve skin condition and reduce symptoms.

In January 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for $850 million. This acquisition was intended to bolster Johnson & Johnson's immunology portfolio by incorporating Proteologix's bispecific antibody programs, which are being developed to treat immune-mediated diseases such as atopic dermatitis and asthma. Proteologix Inc. is a biotechnology company in the United States that focuses on anti-allergy treatments using novel bispecific antibody therapies to target conditions like asthma and atopic dermatitis.

Major players in the anti-allergy medicine market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Perrigo Company plc, Cipla Limited, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd., ALK-Abello A/S, Torii Pharmaceutical Co. Ltd., Biomay Aktiengesellschaft, Kaleo Inc., Immunomic Therapeutics Inc., Circassia Group plc, Sun Pharmaceutical Industries Ltd., Anergis S.A., Aravax Pty Ltd., DBV Technologies S.A., and Desentum Oy.

North America was the largest region in the anti-allergy medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-allergy medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anti-allergy medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-allergy medicine market consists of sales of combination therapies, inhalers, nebulizers, auto-injectors, prefilled syringes, and transdermal patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Allergy Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-allergy medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-allergy medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-allergy medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Leukotriene Inhibitors; Mast Cell Stabilizers; Other Drug Classes
• 2) By Type Of Allergy: Seasonal Allergies; Perennial Allergies; Food Allergies; Skin Allergies; Insect Sting Allergies
• 3) By Formulation: Tablets; Capsules; Syrups; Nasal Sprays; Eye Drops; Injectables
• 4) By Application: Online Pharmacy; Hospital; Offline Pharmacy; Clinic; Other Applications
• 5) By End User: Children; Adults; Geriatric Population; Pregnant Women
• Subsegments:
• 1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines; Third-Generation Antihistamines
• 2) By Corticosteroids: Oral Corticosteroids; Nasal Corticosteroids; Inhaled Corticosteroids; Topical Corticosteroids
• 3) By Decongestants: Oral Decongestants; Nasal Spray Decongestants; Topical Decongestants
• 4) By Leukotriene Inhibitors: Leukotriene Receptor Antagonists; Leukotriene Synthesis Inhibitors
• 5) By Mast Cell Stabilizers: Cromolyn Sodium; Nedocromil Sodium
• 6) By Other Drug Classes: Immunotherapy Agents; Biologics; Monoclonal Antibodies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti-Allergy Medicine Market Characteristics

3. Anti-Allergy Medicine Market Trends And Strategies

4. Anti-Allergy Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Anti-Allergy Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anti-Allergy Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anti-Allergy Medicine Market Growth Rate Analysis
• 5.4. Global Anti-Allergy Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anti-Allergy Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anti-Allergy Medicine Total Addressable Market (TAM)

6. Anti-Allergy Medicine Market Segmentation

• 6.1. Global Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Corticosteroids
• Decongestants
• Leukotriene Inhibitors
• Mast Cell Stabilizers
• Other Drug Classes
• 6.2. Global Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seasonal Allergies
• Perennial Allergies
• Food Allergies
• Skin Allergies
• Insect Sting Allergies
• 6.3. Global Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Syrups
• Nasal Sprays
• Eye Drops
• Injectables
• 6.4. Global Anti-Allergy Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Pharmacy
• Hospital
• Offline Pharmacy
• Clinic
• Other Applications
• 6.5. Global Anti-Allergy Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Geriatric Population
• Pregnant Women
• 6.6. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines
• Second-Generation Antihistamines
• Third-Generation Antihistamines
• 6.7. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Corticosteroids
• Nasal Corticosteroids
• Inhaled Corticosteroids
• Topical Corticosteroids
• 6.8. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Decongestants
• Nasal Spray Decongestants
• Topical Decongestants
• 6.9. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Leukotriene Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukotriene Receptor Antagonists
• Leukotriene Synthesis Inhibitors
• 6.10. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cromolyn Sodium
• Nedocromil Sodium
• 6.11. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunotherapy Agents
• Biologics
• Monoclonal Antibodies

7. Anti-Allergy Medicine Market Regional And Country Analysis

• 7.1. Global Anti-Allergy Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anti-Allergy Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Allergy Medicine Market

• 8.1. Asia-Pacific Anti-Allergy Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Allergy Medicine Market

• 9.1. China Anti-Allergy Medicine Market Overview
• 9.2. China Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Allergy Medicine Market

• 10.1. India Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Allergy Medicine Market

• 11.1. Japan Anti-Allergy Medicine Market Overview
• 11.2. Japan Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Allergy Medicine Market

• 12.1. Australia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Allergy Medicine Market

• 13.1. Indonesia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Allergy Medicine Market

• 14.1. South Korea Anti-Allergy Medicine Market Overview
• 14.2. South Korea Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Allergy Medicine Market

• 15.1. Western Europe Anti-Allergy Medicine Market Overview
• 15.2. Western Europe Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Allergy Medicine Market

• 16.1. UK Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Allergy Medicine Market

• 17.1. Germany Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Allergy Medicine Market

• 18.1. France Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Allergy Medicine Market

• 19.1. Italy Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Allergy Medicine Market

• 20.1. Spain Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Allergy Medicine Market

• 21.1. Eastern Europe Anti-Allergy Medicine Market Overview
• 21.2. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Allergy Medicine Market

• 22.1. Russia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Allergy Medicine Market

• 23.1. North America Anti-Allergy Medicine Market Overview
• 23.2. North America Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Allergy Medicine Market

• 24.1. USA Anti-Allergy Medicine Market Overview
• 24.2. USA Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Allergy Medicine Market

• 25.1. Canada Anti-Allergy Medicine Market Overview
• 25.2. Canada Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Allergy Medicine Market

• 26.1. South America Anti-Allergy Medicine Market Overview
• 26.2. South America Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Allergy Medicine Market

• 27.1. Brazil Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Allergy Medicine Market

• 28.1. Middle East Anti-Allergy Medicine Market Overview
• 28.2. Middle East Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Allergy Medicine Market

• 29.1. Africa Anti-Allergy Medicine Market Overview
• 29.2. Africa Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Allergy Medicine Market Competitive Landscape And Company Profiles

• 30.1. Anti-Allergy Medicine Market Competitive Landscape
• 30.2. Anti-Allergy Medicine Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Allergy Medicine Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. AstraZeneca plc
• 31.3. Novartis AG
• 31.4. GSK plc
• 31.5. Amgen Inc.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Perrigo Company plc
• 31.9. Cipla Limited
• 31.10. Dr. Reddy's Laboratories
• 31.11. Lupin Limited
• 31.12. Zydus Lifesciences Limited
• 31.13. Takeda Pharmaceutical Company Limited
• 31.14. Torrent Pharmaceuticals Ltd.
• 31.15. ALK-Abello A/S

32. Global Anti-Allergy Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Allergy Medicine Market

34. Recent Developments In The Anti-Allergy Medicine Market

35. Anti-Allergy Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Anti-Allergy Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anti-Allergy Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anti-Allergy Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer